Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引：9

作者：

Serban, Dragos ^{[1
,2
]}

Costea, Daniel Ovidiu ^{[3
,4
]}

Zgura, Anca ^{[5
,6
]}

Tudosie, Mihail Silviu ^{[7
,8
]}

Dascalu, Ana Maria ^{[9
,10
]}

Gangura, Gabriel Andrei ^{[1
,11
]}

Smarandache, Catalin Gabriel ^{[1
,2
]}

Sabau, Alexandru Dan ^{[12
,13
]}

Tudor, Corneliu ^{[2
]}

Faur, Mihai ^{[12
,13
]}

Costea, Andreea Cristina ^{[14
]}

Stana, Daniela ^{[10
]}

Balasescu, Simona Andreea ^{[2
]}

Tribus, Laura Carina ^{[15
,16
]}

Tanasescu, Ciprian ^{[12
,13
]}

机构：

[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania

[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania

[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania

[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania

[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania

[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania

[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania

[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania

[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania

[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania

[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania

[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania

[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania

[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania

[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania

来源：

IN VIVO | 2022年 / 36卷 / 01期

关键词：

Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;

D O I：

10.21873/invivo.12674

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.

引用

页码：40 / 48

页数：9

共 50 条

[41] Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Moscetti, Luca
Fabbri, Maria Agnese
Sperduti, Isabella
Fabrizio, Nelli
Frittelli, Patrizia
Massari, Annalisa
Pompei, Luciano
D'Auria, Giuliana
Pofi, Enrico
Ruggeri, Enzo Maria
TUMORI, 2015, 101 (05) : 469 - 473
[42] Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer
Turnbull, Arran K.
Arthur, Laura M.
Renshaw, Lorna
Larionov, Alexey A.
Kay, Charlene
Dunbier, Anita K.
Thomas, Jeremy S.
Dowsett, Mitch
Sims, Andrew H.
Dixon, J. Michael
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (20) : 2270 - U72
[43] The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review
Bakoyiannis, Ioannis
Tsigka, Eleousa-Alexandra
Perrea, Despina
Pergialiotis, Vasilios
CLINICAL DRUG INVESTIGATION, 2016, 36 (02) : 109 - 118
[44] Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: Case reports and review of the literature
Jhaveri, Komal
Halperin, Peter
Shin, Sandra J.
Vahdat, Linda
BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (03) : 315 - 318
[45] Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis
Lee, Young-Kyun
Lee, Eun-Gyeong
Kim, Ha Young
Lee, Youjin
Lee, Seung-Mi
Suh, Dong-Churl
Yoo, Jun-Il
Lee, Seeyoun
JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (46)
[46] ENDOCRINE THERAPY IN BREAST CANCER: THE NEOADJUVANT, ADJUVANT, AND METASTATIC APPROACH
Reinbolt, Raquel E.
Mangini, Neha
Hill, Jordan L.
Levine, Lauren B.
Dempsey, Jessica L.
Singaravelu, Janani
Koehler, Kevin A.
Talley, Allison
Lustberg, Maryam B.
SEMINARS IN ONCOLOGY NURSING, 2015, 31 (02) : 146 - 155
[47] Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women
Mouridsen, Henning T.
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (08) : 1609 - 1621
[48] Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition
Spicer, J.
Ellis, P.
CANCER LETTERS, 2007, 248 (02) : 165 - 174
[49] Fulvestrant - A Novel Endocrine Therapy for Breast Cancer
Johnston, S. J.
Cheung, K. L.
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (10) : 902 - 914
[50] Endocrine Therapy of Breast Cancer
Lumachi, F.
Luisetto, G.
Basso, S. M. M.
Basso, U.
Brunello, A.
Camozzi, V.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (04) : 513 - 522

← 1 2 3 4 5 →